Complex Generics May Be Part Of White House Drug Pricing Response
Document that appears to be fueling upcoming executive order includes ideas for relaxing FDA standards for complex generic approval, which may be one way of creating pressure to lower prices.
You may also be interested in...
As work on policy development and executive orders continues, critics implore Trump to return to his "getting away with murder" roots.
Hearings in July and the fall will follow, but if the first session was any indication, industry doesn't have anything to worry about.
House Energy and Commerce Committee refines FDA Reauthorization Act and adopts a ‘sense of Congress’ resolution on drug pricing, but largely steers clear of other potentially controversial add-ons that could bog down the measure.